Search clinical trials for: Lenvatinib (MTC Cohort)

Total 5167 results

Peking Union Medical College Hospital

Recruiting

Lenvatinib Plus Tislelizumab With or Without TACE in First-line Treatment of Unresectable HCC

Hepatocellular Carcinoma

China
Fudan University

Recruiting

Capecitabine Combined With Lenvatinib and Tislelizumab as Adjuvant Treatment After Resection in Patients With BTC

Biliary Tract Cancer

China
Eisai Co., Ltd.
Merck Sharp & Dohme LLC

Completed

A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma

Hepatocellular Carcinoma

United States, Spain, France, Italy, Japan, Russian Federation, United Kingdom
Institut für Klinische Krebsforschung IKF GmbH...
Merck Sharp & Dohme LLC; Medizinische Hochschule Hannover, Germany, Prof. Dr...

Active, not recruiting

Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab/ IO-based Therapy

Hepatocellular Carcinoma

Germany
SENAI CIMATEC

Recruiting

Study to Assess Safety, Reactogenicity and Immunogenicity of the VACCINE RNA MCTI CIMATEC HDT (HDT-301) Vaccine Against COVID-19

SARS-CoV-2

Brazil
Emergo Therapeutics, Inc.

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy Subjects

Healthy Subjects

United States
Medical University Innsbruck
Merck Sharp & Dohme LLC

Recruiting

Trial Exploring Combined Neoadjuvant Therapy With Pembrolizumab/Lenvatinib + Adjuvant Pembrolizumab in Pat. With NSCLC (INNWOP1)

Non Small Cell Lung Cancer

Austria
Nottingham University Hospitals NHS Trust
Newcastle University; University of Kansas; Macmillan Cancer Support; Bishop Grosseteste...

Terminated

Nutrition Health Literacy of Cancer Patients and Their Support Networks. (NiiCproject)

Cancer | Oncologic Disorders | Nutrition Aspect of Cancer | Haematological Malignancy

United Kingdom
Lighthouse Trust
Centers for Disease Control and Prevention; Ministry of Health, Malawi; United...

Unknown

Evaluation of Pre-Exposure Prophylaxis for High Risk Adolescent Girls and Young Women

HIV/AIDS

Malawi
Centre Hospitalier Universitaire Vaudois

Completed

No Association Between Vitamin C and E Supplementation, Frailty, and Grip Strength Over Five Years: The CoLaus Study (CoLaus)

Frail Elderly Syndrome

Switzerland
Arisan Therapeutics, Inc.
United States Department of Defense; Battelle Memorial Institute; The Defense...

Recruiting

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects

Lassa Virus Infection

United States
Hadassah Medical Organization

Completed

Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis (MSC-pMS)

Multiple Sclerosis
Tetec AG
Winicker Norimed GmbH; Aesculap AG

Completed

Non-interventional Study With NOVOCART® Basic in Patients Treated for Cartilage Defects in the Knee With MAC (NBasic)

Cartilage Diseases

Germany, Switzerland
Peking Union Medical College Hospital

Recruiting

Pembrolizumab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer

Biliary Tract Neoplasms Immunotherapy

China
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors

Alopecia | Survivors of Childhood Cancer

United States
Weill Medical College of Cornell University

Recruiting

A Pilot Study to Determine Fructose Uptake by Primary Human Colorectal Tumors

Colorectal Tumors

United States
Ardea Biosciences, Inc.

Completed

RDEA3170 Tablet and Capsule Bioavailability Study

Healthy

United States
DK Medical Technology (Suzhou) Co., Ltd.
Core Medical (Beijing) Co., Ltd.

Active, not recruiting

A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary Small Vessel Disease

Coronary Small Vessel Disease

China
Chen Xiaoping

Not yet recruiting

Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model.

HCC
Nanfang Hospital, Southern Medical University

Recruiting

Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma

China
Nanfang Hospital, Southern Medical University

Recruiting

Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscore

Gastric Cancer

China
MedSIR
Merck Sharp & Dohme LLC

Active, not recruiting

Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents (PECATI)

Metastatic Thymic Carcinoma | Thymoma Type B3

Spain, France, Italy
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Chang Gung Memorial Hospital; Kaohsiung... and other collaborators

Recruiting

Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment (LenPac)

Advanced Biliary Tract Cancer

Taiwan
Children's Hospital of Fudan University

Recruiting

High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia

Infant | Biliary Atresia | Nutrition Support | Medium-chain Triglyceride

China
Wuhan Union Hospital, China

Recruiting

The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label Study

Hepatocellular Carcinoma

China
RenJi Hospital

Recruiting

Pembrolizumab and LENvatinib in Participants With Hepatocellular Carcinoma (HCC) Before Liver Transplant (PLENTY202001)

Liver Transplant; Complications | Hepatocellular Carcinoma Recurrent

China
Eisai Inc.
Merck Sharp & Dohme LLC

Completed

A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile

Thyroid Cancer

United States, Canada, Germany, Korea, Republic of, Spain, France, Australia, Belgium, Denmark, Israel, Italy, Poland, Romania, Russian Federation, Sweden, United Kingdom
University of North Carolina, Chapel Hill
Philips Oral Healthcare

Completed

Dental Plaque Removal Study (PAU2)

Gingivitis | Gum Disease

United States
Modulation Therapeutics, Inc.
H. Lee Moffitt Cancer Center and Research Institute

Recruiting

Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma

Uveal Melanoma | Metastatic

United States
National University Hospital, Singapore

Recruiting

Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA)

Breast Cancer

Singapore
VA Office of Research and Development

Completed

Continuing the Conversation: Using Narrative Communication to Support Hypertension Self-management in African American Veterans

Hypertension

United States
National Cancer Center, Korea
MSD Korea Ltd.

Enrolling by invitation

Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma (ACCOMPLISH)

Adrenocortical Carcinoma

Korea, Republic of
Centre Hospitalier Universitaire de Saint Etienne

Completed

5 Years Follow-up Evaluation of Deterioration Kidney Biomarkers of HIV Patients (HIVOL2)

HIV

France
Centro Hospitalar Nordeste

Completed

Chemotherapy With DNA Damaging Agents In Colorectal Cancer

Colorectal Cancer
Sun Yat-sen University

Recruiting

The Efficacy of Hepatic Arterial Infusion Chemotherapy (HAIC) Combine Lenvatinib and Durvalumab (HILL) in Advanced Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

China
Affiliated Hospital to Academy of Military Medical...

Unknown

Safety and Efficacy of UC-MSC in Patients With Acute Severe Graft-versus-host Disease

Acute GVH Disease

China
Chugai Pharmaceutical

Completed

Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)

Rheumatoid Arthritis
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Nivolumab for Pediatric and Adult Relapsing/Refractory ALK+, for Evaluation of Response in Patients With Progressive Disease (Cohort 1) or as Consolidative Immunotherapy in Patients in Complete Remission After Relapse (Cohort 2) (NIVO-ALCL)

Relapsing/Refractory ALK+ Anaplastic Large Cell Lymphoma

France, Denmark, Netherlands
Spectrum Health Hospitals

Completed

Phase I: Melphalan, Bendamustine and Carfilzomib for Autologous Transplant in Multiple Myeloma

Multiple Myeloma

United States
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Not yet recruiting

Optimizing PrEP Regimens for Pregnant Women in Sub-Saharan Africa (O-PrEP Study) - Stage 1

Pregnancy | HIV | Prevention

Malawi, Zimbabwe
Immunovant Sciences GmbH

Recruiting

Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease

Thyroid Eye Disease

United States, Hungary, Spain, Latvia, Belgium, Slovakia
Inonu University

Completed

A Comparison of McGrath MAC Versus C-MAC Videolaryngoscopes in Morbidly Obese Patients (mcgrath&cmac)

Morbid Obesity | Difficult Intubation | Videolaryngoscopy

Turkey
Ferring Pharmaceuticals

Recruiting

NOCDURNA PASS Study Using Registries in Denmark, Germany and Sweden

Adverse Drug Event

Germany
Merz North America, Inc.

Completed

An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis

Tinea Corporis

United States, Dominican Republic, Honduras
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Hepatocellular Carcinoma Non-resectable

China
Merck Sharp & Dohme LLC

Active, not recruiting

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-052)

HIV-1 Infection

United States, Australia, Chile, Israel, Japan, United Kingdom
Peking University Cancer Hospital & Institute
Betta Pharmaceuticals Co., Ltd.

Recruiting

Ensatinib in alK-positive Patients Undergoing Initial Treatment for Advanced Non-small Cell Lung Cancer (EFLRWR)

NSCLC Stage IV | NSCLC Stage IIIB | ALK Positive

China
Merck Sharp & Dohme LLC
Eisai Inc.

Active, not recruiting

Safety and Efficacy Study of Pembrolizumab (MK-3475) Combined With Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Advanced Melanoma (MK-7902-003/E7080-G000-312/LEAP-003)-China Extension Study

Malignant Melanoma

China
Eisai Co., Ltd.

Completed

Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)

Carcinoma, Renal Cell

Japan
The Lymphoma Academic Research Organisation
French Innovative Leukemia Organisation

Completed

Escalating Doses of Torisel in Combination With Three Chemotherapies Regimens: R-CHOP, R-FC or R-DHA for Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL). (T³)

Mantle Cell Lymphoma Refractory

France

3

Subscribe